Back
MercadoLibre 10K Form
Buy
59
MELI
MercadoLibre
Last Price:
1,877.48
Seasonality Move:
12.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | MELI/MercadoLibre Quarterly |
2023-11-02 | 10Q | MELI/MercadoLibre Quarterly |
2023-08-03 | 10Q | MELI/MercadoLibre Quarterly |
2023-05-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-11-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-08-04 | 10Q | MELI/MercadoLibre Quarterly |
Receive MELI News And Ratings
See the #1 stock for the next 7 days that we like better than MELI
MELI Financial Statistics
Sales & Book Value
Annual Sales: | $14.47B |
---|---|
Cash Flow: | $1.38B |
Price / Cash Flow: | 16.39 |
Annual Sales: | $78.94 |
Price / Book: | 25.05 |
Profitability
EPS (TTM): | 28.34000 |
---|---|
Net Income (TTM): | $1.44B |
Gross Margin: | $7.21B |
Return on Equity: | 42.62% |
Return on Assets: | 7.53% |
MercadoLibre Earnings Forecast
Key MercadoLibre Financial Ratios
- The Gross Profit Margin over the past 22 years for MELI is 49.79%.
- The Selling, General & Administrative Expenses for MELI have been equal to 17.29% of Gross Profit Margin.
- The Research & Development expenses have been 12.65% of Revenue.
- The Interest Expense is 38.30% of Operating Income.
- The Net Earning history of MELI is 6.82% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 15 years.
MercadoLibre Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Broadline Retail |
Sector: | Consumer Discretionary |
Current Symbol: | MELI |
CUSIP: | 58733R |
Website: | mercadolibre.com |
Debt
Debt-to-Equity Ratio: | 1.31 |
---|---|
Current Ratio: | 1.25 |
Quick Ratio: | 0.86 |
Price-to-Earnings
Trailing P/E Ratio: | 101.61 |
---|---|
Forward P/E Ratio: | 42.75 |
MELI Technical Analysis vs Fundamental Analysis
Buy
59
MercadoLibre (MELI)
is a Buy
Is MercadoLibre a Buy or a Sell?
-
MercadoLibre stock is rated a Buy
The current MercadoLibre [MELI] share price is $1,930.95. The Score for MELI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.